Dolutegravir and Nuwiq recombinant
Determining the interaction of Dolutegravir and Nuwiq recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Nuwiq (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dolutegravir-NuZole
- Dolutegravir-Nuzyra
- Dolutegravir-Nuzyra (Omadacycline Injection)
- Dolutegravir-Nuzyra (Omadacycline Tablets)
- Dolutegravir-Nuzyra Intravenous
- Dolutegravir-Nuzyra oral/injection
- Nuwiq recombinant-Dolutegravir 10 mg
- Nuwiq recombinant-Dolutegravir 25 mg and 50 mg
- Nuwiq recombinant-Dolutegravir and lamivudine
- Nuwiq recombinant-Dolutegravir and rilpivirine
- Nuwiq recombinant-Dolutegravir Sodium
- Nuwiq recombinant-Dolutegravir Sodium And Lamivudine